Abstract #2638

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI

Alina Tudorica¹, Karen Y Oh¹, Stephen Y-C Chui¹, Nicole Roy¹, Megan L Troxell¹, Arpana Naik¹, Kathleen Kemmer¹, Yiyi Chen¹, Megan L Holtorf¹, Aneela Afzal¹, Charles S Springer, Jr¹, Xin Li¹, and Wei Huang¹

¹Oregon Health & Science University, Portland, OR, United States

DCE-MRI was performed in 28 breast cancer patients (29 tumors) before, during, and after neoadjuvant chemotherapy (NACT). Several DCE-MRI pharmacokinetic (PK) parameters were found to be good early predictors of pathologic complete response (pCR) vs. non-pCR after only one NACT cycle. In addition, several PK parameters and tumor size were significantly correlated with pathologically measured residual cancer burden (RCB).

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.